Giannetti Vincent, Caley Charles F, Kamal Khalid M, Covvey Jordan R, McKee Jerry, Wells Barbara G, Najarian Dean M, Dunn Tyler J, Vadagam Pratyusha
Division of Pharmaceutical, Administrative and Social Sciences, Duquesne University School of Pharmacy, 600 Forbes Ave, Pittsburgh, PA, 15282, USA.
Department of Pharmacy Practice, Western New England University College of Pharmacy and Health Sciences, 1215 Wilbraham Road, Springfield, MA, 01119, USA.
Int J Clin Pharm. 2018 Oct;40(5):1096-1105. doi: 10.1007/s11096-018-0619-7. Epub 2018 Jun 4.
Background Half of Americans experience mental illness during their lifetime. Significant opportunity exists for community pharmacists to deliver services to these patients; however, personal and practice-related barriers may prevent full engagement. Objective To assess the demographics, practice characteristics, service provision, stigma, attitudes and beliefs of a national sample of community pharmacists towards individuals with mental illness. Setting National random sample of 3008 community pharmacists in the USA. Method 101-item cross-sectional mailed survey questionnaire on: (1) demographics, (2) knowledge and practice characteristics, (3) provision of clinical pharmacy services, and (4) comparative opinions. Main outcome measure Scaled measures of service provision (comfort, confidence, willingness and interest) and comparative opinions (stigma, attitudes and beliefs) of mental illness, four linear regression models to predict service provision. Results A total of 239 responses were received (response rate 7.95%). Across pharmacy services, ratings for willingness/interest were higher than those for comfort/confidence. Pharmacists who reported providing medication therapy management (MTM) services for patients reported higher comfort (18.36 vs. 17.46, p < 0.05), confidence (17.73 vs. 16.01, p < 0.05), willingness (20.0 vs. 18.62, p < 0.05) and interest (19.13 vs. 17.66, p < 0.05). Pharmacists with personal experience with mental illness also resulted in higher scores across all four domains of service provision, lower levels of stigma (18.28 vs. 20.76, p < 0.05) and more positive attitudes (52.24 vs. 50.53, p < 0.01). Regression analyses demonstrated increased frequency of MTM service delivery and more positive attitudes as significantly predictive across all four models for comfort, confidence, willingness and interest. Increased delivery of pharmacy services was significantly associated with both willingness and interest to provide mental illness-specific services. Conclusion Despite willingness/interest to provide services to patients with mental illness, decreased levels of comfort/confidence remain service-related barriers for community pharmacists.
一半的美国人在其一生中会经历精神疾病。社区药剂师有很大机会为这些患者提供服务;然而,个人和与执业相关的障碍可能会阻碍他们充分参与。目的:评估全国社区药剂师样本对患有精神疾病个体的人口统计学特征、执业特点、服务提供情况、耻辱感、态度和信念。地点:美国3008名社区药剂师的全国随机样本。方法:采用101项横断面邮寄调查问卷,内容包括:(1)人口统计学特征,(2)知识和执业特点,(3)临床药学服务的提供情况,以及(4)比较性意见。主要结局指标:精神疾病服务提供情况(舒适度、信心、意愿和兴趣)以及比较性意见(耻辱感、态度和信念)的量表测量,四个线性回归模型用于预测服务提供情况。结果:共收到239份回复(回复率7.95%)。在各项药学服务中,意愿/兴趣评分高于舒适度/信心评分。报告为患者提供药物治疗管理(MTM)服务的药剂师在舒适度(18.36对17.46,p<0.05)、信心(17.73对16.01,p<0.05)、意愿(20.0对18.62,p<0.05)和兴趣(19.13对17.66,p<0.05)方面得分更高。有精神疾病个人经历的药剂师在服务提供的所有四个领域得分也更高,耻辱感水平更低(18.28对20.76,p<0.05),态度更积极(52.24对50.53,p<0.01)。回归分析表明,MTM服务提供频率的增加和更积极的态度在舒适度、信心、意愿和兴趣的所有四个模型中均具有显著预测性。药学服务提供的增加与提供精神疾病特定服务的意愿和兴趣均显著相关。结论:尽管有意愿/兴趣为患有精神疾病的患者提供服务,但舒适度/信心水平的降低仍然是社区药剂师与服务相关的障碍。